239 results on '"Schmidt-Wolf, Ingo G.H."'
Search Results
2. Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer
3. Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells
4. Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature [Primäres kleinzelliges Ösophaguskarzinom: Patientendaten-Metaanalyse und Review der Literatur ]
5. Cytokine-induced killer cells are type II natural killer T cells
6. High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma
7. Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
8. High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma
9. Questions and emotional expressions from patients and companions while participating in multidisciplinary tumor conferences in breast and gynecological cancer centers
10. Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.
11. Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma
12. A rare imaging presentation with multisystemic clinicopathological features of Langerhans cell histiocytosis: Case report and literature review
13. Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
14. In vivo efficacy of griseofulvin against multiple myeloma
15. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?
16. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
17. Endoscopy in patients with acute leukaemia after intensive chemotherapy
18. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
19. Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients
20. Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma
21. A Matched-pair Analysis on the Effect of Migration Background on Response Rates and Survival of Cancer Patients Treated at a Comprehensive Cancer Center in Germany
22. Presence of the Transmembrane Protein Neuropilin in Cytokine-induced Killer Cells
23. Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
24. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
25. VH gene analysis of primary CNS lymphomas
26. Long-Term Survival of a Patient with Small Cell Lung Cancer after Nine Lines of Chemotherapy and Radiation
27. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells
28. Misleading Statements in Industry-Sponsored Meta-Analysis of Itraconazole
29. Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation—a retrospective analysis
30. Telomerase Pulsed Dendritic Cells for Immunotherapy for Renal Cell Carcinoma
31. Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
32. Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy
33. Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate
34. Non-viral and hybrid vectors in human gene therapy: an update
35. Induction of Apoptosis in B Lymphoma Cells by Activation with CD40L
36. Increased Sensitivity of Myeloid Leukemia Cell Lines: Potential of Lovastatin as Bone-Marrow-Purging Agent
37. Immune Check Point CD40–CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells
38. Griseofulvin Efficiently Induces Apoptosis in In Vitro Treatment of Lymphoma and Multiple Myeloma
39. Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide
40. Efficacy of cytokine-induced killer cells targeting CD40 and GITR.
41. Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.
42. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL
43. In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma
44. Increased effect of IMiDs by addition of cytokine-induced killer cells in multiple myeloma
45. Hochdosistherapie mit autologer Stammzelltransplantation bei Patienten mit diffus großzelligem Non-Hodgkin-Lymphom
46. Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
47. CIK Cells and HDAC Inhibitors in Multiple Myeloma.
48. Increased effect of IMiDs by addition of cytokine-induced killer cells in multiple myeloma.
49. Identification of biomarkers for overall survival of patients with metastatic renal cell carcinoma treated with MGN1601.
50. Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.